FLT3 and acute myeloid leukemia: Considering that AML cell lines may have limitations in reflecting the effect of FLT3 inhibitors, we established two FLT3-ITD AML relapsed patient-derived xenograft model to further evaluate the anti-FLT3-ITD AML potency of GNF-7.